Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans
- PMID: 25655570
- PMCID: PMC4345860
- DOI: 10.1161/JAHA.114.001224
Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans
Abstract
Background: Though left ventricular mass (LVM) predicts cardiovascular events (CVD) and mortality in African Americans, limited data exists on factors contributing to change in LVM and its prognostic significance. We hypothesized that baseline blood pressure (BP) and body mass index (BMI) and change in these variables over time are associated with longitudinal increases in LVM and that such increase is associated with greater incidence of CVD.
Methods and results: We investigated the clinical correlates of change in standardized logarithmically transformed-LVM indexed to height2.7 (log-LVMI) and its association with incident CVD in 606 African Americans (mean age 58±6 years, 66% women) who attended serial examinations 8 years apart. Log-LVMI and clinical covariates were standardized within sex to obtain z scores for both visits. Standardized log-LVMI was modeled using linear regression (correlates of change in standardized log-LVMI) and Cox proportional hazards regression (incidence of CVD [defined as coronary heart disease, stroke, heart failure and intermittent claudication]). Baseline clinical correlates (standardized log-LVM, BMI, systolic BP) and change in systolic BP over time were significantly associated with 8-year change in standardized log-LVMI. In prospective analysis, change in standardized LVM was significantly (P=0.0011) associated with incident CVD (hazards ratio per unit standard deviation change log-LVMI 1.51, 95% CI 1.18 to 1.93).
Conclusions: In our community-based sample of African Americans, baseline BMI and BP, and change in BP on follow-up were key determinants of increase in standardized log-LVMI, which in turn carried an adverse prognosis, underscoring the need for greater control of BP and weight in this group.
Keywords: African Americans; blood pressure; cardiovascular disease; cardiovascular events; left ventricular mass risk factors.
© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Figures
References
-
- Fox ER, Taylor HA, Jr, Benjamin EJ, Ding J, Liebson PR, Arnett D, Quin EM, Skelton TN. Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke. 2005; 36:546-550. - PubMed
-
- Taylor HA, Penman AD, Han H, Dele‐Michael A, Skelton TN, Fox ER, Benjamin EJ, Arnett DK, Mosley TH., Jr Left ventricular architecture and survival in African‐Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2007; 99:1413-1420. - PMC - PubMed
-
- Benjamin EJ, Levy D. Why is left ventricular hypertrophy so predictive of morbidity and mortality? Am J Med Sci. 1999; 317:168-175. - PubMed
-
- Nunez E, Arnett DK, Benjamin EJ, Liebson PR, Skelton TN, Taylor H, Andrew M. Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005; 45:58-63. - PubMed
-
- Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension. 2004; 43:1182-1188. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- R01-HL-08675/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- N01-HC-25915/HC/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- HHSN268201300048C/HL/NHLBI NIH HHS/United States
- R01HL080124/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201300049C/HL/NHLBI NIH HHS/United States
- P20 MD006899/MD/NIMHD NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201300047C/HL/NHLBI NIH HHS/United States
- HHSN268201300050C/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- R01 HL080124/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
